OR WAIT null SECS
May 01, 2023
Article
Announced on May 1, the CRL from the FDA expressed concerns related to manufacturing control strategy, but did not express concern related to clinical data submitted as part of the NDA package for TransCon PTH.
April 19, 2023
Unadjusted rates of hypoparathyroidism were higher in patients who underwent total thyroidectomy and parathyroidectomy at both 30 days and 6 months.
April 18, 2023
Those with ≥67% of albumin-corrected serum calcium measurements outside of the study-defined limits had 1.9-fold higher odds of experiencing a cardiovascular event compared with patients with
April 11, 2023
Leveraging data from more than 40,000 Veterans with primary hyperparathyroidism, a new NIA-funded study details the impact of parathyroidectomy on long-term kidney function among these patients.
March 30, 2023
According to a recent study, nearly 1 in 4 patients with either hypothyroidism or subclinical hypothyroidism suffer from a vitamin B12 deficiency.
February 02, 2023
This week, the FDA announced that 27 lots of levothyroxine sodium oral solution, used for hypothyroidism, were being recalled due to potentially being subpotent.
